相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells
Alexandros Karampatzakis et al.
FRONTIERS IN IMMUNOLOGY (2021)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies
Junji Tanaka et al.
BLOOD REVIEWS (2020)
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
Sonia Boyer-Suavet et al.
FRONTIERS IN IMMUNOLOGY (2020)
Exploiting Human NK Cells in Tumor Therapy
Paola Vacca et al.
FRONTIERS IN IMMUNOLOGY (2020)
Natural Born Killers: NK Cells in Cancer Therapy
S. Elizabeth Franks et al.
CANCERS (2020)
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies
Tobias Bald et al.
NATURE IMMUNOLOGY (2020)
CD56dimCD57-NKG2C+NK cells retaining proliferative potential are possible precursors of CD57+NKG2C+memory-like NK cells
Polina A. Kobyzeva et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
PD-1-positive Natural Killer Cells have a weaker antitumor function than that of PD-1-negative Natural Killer Cells in Lung Cancer
Chao Niu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
NK cells: An attractive candidate for cancer therapy
Behnaz Valipour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
Monika Enqvist et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK Cells in the Treatment of Hematological Malignancies
Ana P. Gonzalez-Rodriguez et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
Evelyn O. Ojo et al.
SCIENTIFIC REPORTS (2019)
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells
Yufeng Wang et al.
NATURE IMMUNOLOGY (2019)
Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells
Katja Srpan et al.
JOURNAL OF CELL BIOLOGY (2018)
NK CellsMediateaCrucialGraft-versusLeukemia EffectinHaploidentical-HSCT to CureHigh-RiskAcuteLeukemia
Franco Locatelli et al.
TRENDS IN IMMUNOLOGY (2018)
High-Risk Leukemia: Past, Present, and Future Role of NK Cells
Melissa Mavers et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
Stephan Kloss et al.
HUMAN GENE THERAPY (2017)
Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21
Maria A. Streltsova et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
Evan Lusty et al.
MOLECULAR IMMUNOLOGY (2017)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells
Chao Niu et al.
BMC IMMUNOLOGY (2015)
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
Chandan Verma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line
Duk Seong Bae et al.
BLOOD RESEARCH (2014)
Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity
Dominika Rudnicka et al.
BLOOD (2013)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
Selective Role of Mevalonate Pathway in Regulating Perforin but Not FasL and TNFalpha Release in Human Natural Killer Cells
Alessandro Poggi et al.
PLOS ONE (2013)
Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer
Suliman Y. Al Omar et al.
IMMUNOLOGY (2011)
Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-γ Contributes to Modulate Immune Responses
Claire Germain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
Re-educating natural killer cells
Joseph C. Sun
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Increased secretion of hyperimmune antibodies following lipopolysaccharide stimulation of CD40-activated human B cells in vitro
Nellie Dumont et al.
IMMUNOLOGY (2009)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Tcr ζ-chain downregulation:: Curtailing an excessive inflammatory immune response
M Baniyash
NATURE REVIEWS IMMUNOLOGY (2004)
分享论文
